Give 2-DG medicine to Kovid-19 patients under the advice and supervision of doctors: DRDO
New Delhi. The emergency use of 2-deoxy-D-glucose (2-DG) drug made by DRDO for the treatment of corona infections has been approved. However, there are still many questions regarding this like who can take this medicine? What kind of patients are benefiting from its use? Now DRDO has issued instructions regarding its use. DRDO has tweeted from its official Twitter handle that this medicine can be given to Kovid-19 patients under the suggestion and supervision of doctors.
This drug is manufactured by DRDO in association with Reddy’s Laboratories. This DRDO medicine comes in the form of a powder in a sachet, which is dissolved in water and given to the patient by mouth. This DRDO medicine comes in the form of a powder in a sachet, which is dissolved in water and given to the patient by mouth. It accumulates in virus-infected cells and inhibits the growth of the virus by inhibiting the energy production of the virus. This medicine is as a boon for those patients who are heavily dependent on oxygen.
DRDO has issued valid instructions on behalf of the Drug Controller General of India. According to this, this medicine can be given to those corona patients who are hospitalized.
This medicine should be given to the patient within or before the first 10 days of corona infection.
2DG drug has not yet been tested on uncontrolled diabetes, patients with severe heart disease, ARDS, patients with impaired kidney function. Therefore these people should not be given this medicine.
2DG medicine should also not be given to pregnant and lactating women. Also, this medicine should not be given to adolescents under the age of 18 years.
If patients and family members want this medicine, then they should contact Dr Reddy’s Lab in Hyderabad for supply from their hospital.